This article is more than 5 years old. Information may no longer be current.

VIDEO: Aerie announces Rocklatan launch

ByVicente Anido Jr., PhD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO ― At the Ophthalmology Innovation Summit, Vicente J. Anido Jr., PhD, chairman and CEO of Aerie Pharmaceuticals, discusses the market launch of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in the U.S., as well as the company’s pipeline and progress in international markets.